<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26312689</article-id>
      <article-id pub-id-type="pmc">4540523</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153373</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Post-kala-azar dermal Leishmaniasis in two different clinical
contexts<xref ref-type="fn" rid="fn01">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Barroso</surname>
            <given-names>Daniel Holanda</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silva</surname>
            <given-names>Cla&#xFA;dia Elise Ferraz</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vasconcelos</surname>
            <given-names>Ana Carolina Depes Perdigao e</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cavalcanti</surname>
            <given-names>Silvana Maria de Morais</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Brito</surname>
            <given-names>Maria Edileuza Felinto</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Medeiros</surname>
            <given-names>Angela Cristina Rapela</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Universidade de Pernambuco (UPE) - Recife (PE),
Brazil.</aff>
      <aff id="aff02"><label>2</label>Universidade Federal de Pernambuco (UFPE) - Recife (PE),
Brazil.</aff>
      <aff id="aff03"><label>3</label>Funda&#xE7;&#xE3;o Oswaldo Cruz (Fiocruz) - Recife (PE),
Brazil.</aff>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Daniel Holanda Barroso, Rua Arn&#xF3;bio Marqu&#xEA;s 310,
Santo Amaro, 50100-130 - Recife - PE, Brazil. E-mail:
<email>danielhbarroso@gmail.com</email></corresp>
        <fn fn-type="conflict">
          <p>Conflict of Interest: None.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>3 Suppl 1</issue>
      <fpage>108</fpage>
      <lpage>110</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>3</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>In Brazil, visceral Leishmaniasis is caused by Leishmania chagasi. The development of
cutaneous lesions in visceral leishmaniasis patients has been described in two
different clinical contexts. Patients with compromised immunity can develop skin
lesions as a direct consequence of a current visceral disease. Equally, patients with
a history of kala-azar and progressive, immune improvement occasionally develop skin
lesions as a consequence of immune reconstitution infl ammatory syndrome. These cases
manifest in similar fashion to the classic form of post-kala-azar dermal
Leishmaniasis. We describe different cases that exemplify these two clinical
presentations.</p>
      </abstract>
      <kwd-group>
        <kwd>Dermatology</kwd>
        <kwd>HIV</kwd>
        <kwd>Immune reconstitution inflammatory syndrome</kwd>
        <kwd>Leishmania infantum</kwd>
        <kwd>Leishmaniasis</kwd>
        <kwd>Skin diseases</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>The development of skin lesions in the context of <italic>Leishmania sp</italic> and HIV
co-infection has been described in two different situations.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup> Habitually,
cutaneous involvement occurs after starting of highly active antiretroviral therapy
(HAART) in the context of immune reconstitution syndrome. <sup><xref rid="r01" ref-type="bibr">1</xref></sup> Dermatological lesions can also occur due to a current
kala-azar episode.<sup><xref rid="r02" ref-type="bibr">2</xref></sup></p>
    </sec>
    <sec>
      <title>CASE REPORTS</title>
      <sec>
        <title>Case 1</title>
        <p>A male AIDS sufferer of 6 years, aged 35, needed assistance at the dermatology
department during antiretroviral therapy, due to erythematous nodules, some of which
were confluent, leading to infiltrated patches with mild scaling that had emerged one
year and three months earlier (<xref ref-type="fig" rid="f01">Figures 1</xref> and
<xref ref-type="fig" rid="f02">2</xref>). The lesions were disseminated. At that
point, he did not present systemic signs or symptoms. He had experienced a visceral
Leishmaniasis episode four years previously, treated with Amphotericin B, and
subsequently underwent prophylaxis with this drug, due to frequent relapses of the
disease. Histopathological examination of the skin sample showed amastigote forms of
<italic>Leishmania sp</italic>. The PCR for <italic>Leishmania chagasi</italic>,
using the Primers RV1 and RV2, was positive and the Montenegro's reaction was 14mm.
At the time, the CD4+ cell count was 330cel/mm<sup>3</sup>, while the CD4+ cell count
was 92cels/mm<sup>3</sup>, three months before lesions developed. This patient was
treated using Amphotericin B, with complete resolution of skin lesions.</p>
        <fig id="f01" orientation="portrait" position="float">
          <label>FIGURE 1</label>
          <caption>
            <p>Papular and nodular lesions on the trunk. They were also present on the
extremities and back</p>
          </caption>
          <graphic xlink:href="abd-90-03-s1-0108-g01"/>
        </fig>
        <fig id="f02" orientation="portrait" position="float">
          <label>FIGURE 2</label>
          <caption>
            <p>Facial lesions</p>
          </caption>
          <graphic xlink:href="abd-90-03-s1-0108-g02"/>
        </fig>
      </sec>
      <sec>
        <title>Case 2</title>
        <p>A male, aged 42, HIV-positive for 13 years, undergoing irregular use of
antiretroviral therapy, sought assistance due to fever, weight loss and skin lesions
that had appeared in the two preceding months. Physical examination revealed
disseminated, slightly erythematous papules and nodules, as well as papular lesions
on the palate (<xref ref-type="fig" rid="f03">Figures 3</xref> and <xref ref-type="fig" rid="f04">4</xref>). He had a 4-year history of visceral
Leishmaniasis and since then, had been under prophylactic therapy with amphotericin
B. At that point, the CD4+ cell count was 56 cells/mm<sup>3</sup>, while two months
before skin lesions developed, the CD4+ cell count was 108cells/mm<sup>3</sup>.
<italic>Leishmania sp</italic> amastigotes were present on the myelogram, while
the PCR, using the RV1 and RV2 primers, was positive in peripheral blood. The patient
was treated with Lipossomal Amphotericin B, leading to complete resolution of the
visceral and cutaneous condition.</p>
        <fig id="f03" orientation="portrait" position="float">
          <label>FIGURE 3</label>
          <caption>
            <p>Papules and nodules on the abdomen. Similar lesions were present throughout the
body</p>
          </caption>
          <graphic xlink:href="abd-90-03-s1-0108-g03"/>
        </fig>
        <fig id="f04" orientation="portrait" position="float">
          <label>FIGURE 4</label>
          <caption>
            <p>Lesions on the palate</p>
          </caption>
          <graphic xlink:href="abd-90-03-s1-0108-g04"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>We present two rare cases of disease association. The development of skin lesions in
patients with HIV/Kala-azar coinfection has been described in two different situations.
<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup></p>
      <p>Cutaneous lesions can develop in the context of immune reconstitution inflammatory
syndrome (IRIS), caused by Leishmania. <sup><xref rid="r01" ref-type="bibr">1</xref></sup> IRIS comprises a group of disorders that occur after some degree of
immune restoration, which results in pathological inflammation to pathogens and their
antigens. <sup><xref rid="r03" ref-type="bibr">3</xref></sup> Clinical manifestations
depend on the agent involved. <sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup> The diagnosis is clinical and
opportunistic infections should be considered in the differential. <sup><xref rid="r04" ref-type="bibr">4</xref></sup> In HIV-positive individuals, one
essential criterion for diagnosis is that patients be receiving antiretroviral therapy,
with strong virological and immunological responses, meaning an increase in CD4+ cell
count from the baseline and a decrease in HIV RNA level. <sup><xref rid="r03" ref-type="bibr">3</xref></sup></p>
      <p>IRIS cases related to Leishmania generally present with post-kala-azar dermal
Leishmaniasis (PKDL), with a mean CD4<sup>+</sup> cell count of 175 cells/mm<sup>3</sup>
when skin lesions emerge. <sup><xref rid="r01" ref-type="bibr">1</xref></sup> Similarly
to the classical form of PKDL, the ability to mount an immunologic response to the
parasite still present in skin has been implicated in the development of cutaneous
lesions. <sup><xref rid="r05" ref-type="bibr">5</xref></sup> Papules and nodules that
are commonly located on the cephalic region typically occur at variable moments once the
visceral disease is cured. <sup><xref rid="r06" ref-type="bibr">6</xref></sup> Case 1 is
an example of PKDL in the context of IRIS, as demonstrated by the increasing CD4+ cell
counts and the good immunologic response, confirmed by the positive Montenegro&#x2019;s skin
test. Furthermore, the patient did not show signs of visceral involvement, which would
be expected in a case of visceral Leishmaniasis with secondary skin involvement.</p>
      <p>Another possible dermal presentation of the HIV/kala-azar co-infection is the emergence
of disseminated, cutaneous lesions during an active, visceral Leishmaniasis
episode<sup><xref rid="r01" ref-type="bibr">1</xref></sup>. The most common
symptoms of kala-azar in HIV-positive individuals are paleness (91.4% of cases) and
fever (85.9% of cases).<sup><xref rid="r07" ref-type="bibr">7</xref></sup> Moreover,
patients with active infection habitually present moderate to severe immunosuppression
and the mean CD4<sup>+</sup> count is between 44 and 123 cells. <sup><xref rid="r08" ref-type="bibr">8</xref>,<xref rid="r09" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>Patient 2 presented signs of visceral involvement caused by Leishmania and his CD4+ cell
count was decreasing. This data support the diagnosis of a kala-azar episode with
secondary skin involvement in a patient with progressive immune depletion.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>How to cite this article:</bold> Barroso DH, Silva CEF, Vasconcelos ACDP,
Cavalcanti SMM, Brito MEF, Medeiros ACR. Post-Kala-azar dermal Leishmaniasis in two
different clinical contexts. An Bras Dermatol. 2015;90 (3 Suppl 1):S108-10</p>
      </fn>
      <fn fn-type="other" id="fn01">
        <label>*</label>
        <p>Work performed at the Hospital Universit&#xE1;rio Oswaldo Cruz - Universidade de
Pernambuco (UPE) - Recife (PE), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Antinori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Longhi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bestetti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Piolini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Acquaviva</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Foschi</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Post-kala-azar dermal leishmaniasis as an immune reconstitution
inflammatory syndrome in a patient with acquired immune deficiency
syndrome</article-title>
          <source>Br J Dermatol</source>
          <year>2007</year>
          <volume>157</volume>
          <fpage>1032</fpage>
          <lpage>1036</lpage>
          <pub-id pub-id-type="pmid">17854365</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonz&#xE1;lez-Beato</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Moyano</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>S&#xE1;nchez</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gonz&#xE1;lez-Beato</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez-Molina</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Miralles</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Kaposi's sarcoma-like lesions and other nodules as cutaneous
involvement in AIDS-related visceral leishmaniasis</article-title>
          <source>Br J Dermatol</source>
          <year>2000</year>
          <volume>143</volume>
          <fpage>1316</fpage>
          <lpage>1318</lpage>
          <pub-id pub-id-type="pmid">11122042</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elston</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Thaker</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Immune reconstitution inflammatory syndrome</article-title>
          <source>Int J STD AIDS</source>
          <year>2009</year>
          <volume>20</volume>
          <fpage>221</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="pmid">19304962</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huis in 't Veld</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Colebunders</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The immune reconstitution inflammatory syndrome related to HIV
co-infections: a review</article-title>
          <source>Eur J Clin Microbiol Infect Dis</source>
          <year>2012</year>
          <volume>31</volume>
          <fpage>919</fpage>
          <lpage>927</lpage>
          <pub-id pub-id-type="pmid">21964588</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ridolfo</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Gervasoni</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Antinori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pizzuto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Santambrogio</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Trabattoni</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Post-kala-azar Dermal Leishmaniasis During Highly Active
Antiretroviral Therapy in an AIDS Patient Infected with Leishmania
infantum</article-title>
          <source>J Infect</source>
          <year>2000</year>
          <volume>40</volume>
          <fpage>199</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">10841104</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zijlstra</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Musa</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Khalil</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>el-Hassan</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>el-Hassan</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Post-kala-azar dermal leishmaniasis</article-title>
          <source>Lancet Infect Dis</source>
          <year>2003</year>
          <volume>3</volume>
          <fpage>87</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">12560194</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lima</surname>
              <given-names>IP</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Holanda</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Harhay</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Human immunodeficiency virus/Leishmania infantum in the first foci of
urban American visceral leishmaniasis: clinical presentation from 1994 to
2010</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2013</year>
          <volume>46</volume>
          <fpage>156</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="pmid">23666663</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jarvis</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Lockwood</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>Clinical aspects of visceral leishmaniasis in HIV
infection</article-title>
          <source>Curr Opin Infect Dis</source>
          <year>2013</year>
          <volume>26</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">23221770</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexandrino-de-Oliveira</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Santos-Oliveira</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Dorval</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Da-Costa</surname>
              <given-names>Fd</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>da Cunha</surname>
              <given-names>RV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>HIV/AIDS associated visceral leishmaniasis in patients from an endemic
area in Centralwest Brazil</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>2010</year>
          <volume>105</volume>
          <fpage>692</fpage>
          <lpage>697</lpage>
          <pub-id pub-id-type="pmid">20835619</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Souza</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Biscione</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Greco</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Rabello</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Slow clinical improvement after treatment initiation in Leishmania/HIV
coinfected patients</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2012</year>
          <volume>45</volume>
          <fpage>147</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="pmid">22534981</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
